A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of antigens from severe acute respiratory syndrome-associated coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus di
| Company | Devices | Share |
|---|---|---|
| Watmind Usa | 27 | 53% |
| Wondfo Usa Co., Ltd. | 4 | 8% |
| Alere Scarborough, Inc. | 3 | 6% |
| Inbios International, Inc | 3 | 6% |
| Genbody Inc. | 3 | 6% |
| Lumiquick Diagnostics, Inc. | 2 | 4% |
| Coretests, Inc. | 2 | 4% |
| Genabio Diagnostics Inc. | 2 | 4% |
| Phase Scientific International Limited | 1 | 2% |
| Nano-Ditech Corporation | 1 | 2% |
| Sekisui Diagnostics, Llc | 1 | 2% |
| Quidel Corporation | 1 | 2% |
Company = labeler of record on GUDID. 13 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| QKP | Coronavirus Antigen Detection Test System. | 28 |
| QYT | Over-The-Counter Covid-19 Antigen Test | 14 |
| QVF | Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Vi | 5 |
| QMN | Covid-19 Multi-Analyte Antigen Device | 4 |
| PSZ | Devices Detecting Influenza A, B, And C Virus Antigens | 1 |
| QKP | Coronavirus antigen detection test system. | 1 |
Use these as the dimensions to specify in a tender line.
51 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "SARS-CoV-2 antigen IVD, kit, rapid ICT, clinical", from 13 companies. The largest labeler is Watmind Usa with 53% of records.
QKP (Coronavirus Antigen Detection Test System.), QYT (Over-The-Counter Covid-19 Antigen Test), QVF (Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Vi), QMN (Covid-19 Multi-Analyte Antigen Device)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add sars-cov-2 antigen ivd, kit, rapid ict, clinical to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.